Gene Location [1]
MAP kinase signaling

KRAS Mutation is present in 14.73% of AACR GENIE cases, with colorectal adenocarcinoma, non-small cell lung carcinoma, pancreatic exocrine neoplasm, uterine corpus neoplasm, and ovarian neoplasm having the greatest prevalence [4].

Top Disease Cases with KRAS Mutation

Significance of KRAS Mutation in Diseases

Malignant Solid Tumor +

Non-Small Cell Lung Carcinoma +

Colorectal Carcinoma +

Acute Myeloid Leukemia +

Pancreatic Carcinoma +

Non-Hodgkin Lymphoma +

Melanoma +

Myelodysplastic Syndromes +

Breast Carcinoma +

Chronic Myelomonocytic Leukemia +

Multiple Myeloma +

Pancreatic Ductal Adenocarcinoma +

Colorectal Adenocarcinoma +

Ovarian Carcinoma +

Acute Lymphoblastic Leukemia +

Head And Neck Squamous Cell Carcinoma +

Glioma +

Colon Carcinoma +

Lung Adenocarcinoma +

Bladder Carcinoma +

Esophageal Carcinoma +

Diffuse Large B-Cell Lymphoma +

Renal Cell Carcinoma +

Neuroblastoma +

Neurofibromatosis Type 1 +

Endometrial Carcinoma +

Cholangiocarcinoma +

Lung Carcinoma +

Malignant Ovarian Epithelial Tumor +

Gastric Carcinoma +

Cancer +

Germ Cell Tumor +

Urothelial Carcinoma +

Thyroid Gland Carcinoma +

Malignant Peripheral Nerve Sheath Tumor +

Squamous Cell Lung Carcinoma +

Papillary Renal Cell Carcinoma +

Poorly Differentiated Thyroid Gland Carcinoma +

Mantle Cell Lymphoma +

Small Cell Lung Carcinoma +

Rhabdomyosarcoma +

Histiocytic And Dendritic Cell Neoplasm +

Thyroid Gland Follicular Carcinoma +

Thyroid Gland Papillary Carcinoma +

Lymphoma +

Sarcoma +

Chronic Myeloid Leukemia +

Soft Tissue Sarcoma +

Glioblastoma +

Head And Neck Carcinoma +

Prostate Carcinoma +

Gastrointestinal Stromal Tumor +

Hepatocellular Carcinoma +

Clear Cell Renal Cell Carcinoma +

Anaplastic Astrocytoma +

Double-Hit Lymphoma +

Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable +

Peripheral T-Cell Lymphoma +

Peritoneal Mesothelioma +

Pleural Mesothelioma +

Refractory Anemia With Excess Blasts-2 +

Rhabdoid Tumor +

Schwannoma +

Secondary Acute Myeloid Leukemia +

Therapy-Related Acute Myeloid Leukemia +

Thymic Carcinoma +


1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20170629. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. Liu X, Wu C, Li C, and Boerwinkle E. dbNSFP v3.0: A one-stop database of functional predictions and annotations for human nonsynonymous and splice site SNVs. Human Mutation. 2015;37:235-241.

Liu X, Jian X, and Boerwinkle E. dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions. Human Mutation. 2011;32:894-899.

4. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 4. This dataset does not represent the totality of the genetic landscape; see paper for more information.

5. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.